A moonlighting enzyme suppresses immunogenic mitochondrial double-stranded RNAs, balancing longevity and innate immunity in worms and human cells.
Three things to remember
- Mitochondrial dsRNAs accumulate with age and trigger aberrant immune activation.
- FARS-1/FARSA binds dsRNAs via a novel domain, reducing their levels.
- Inhibiting FARS-1 boosts immunity but may trade off longevity.
Source
This signal is based on Phenylalanyl-tRNA synthetase FARS-1/FARSA balances longevity and immunity by downregulating endogenous mitochondrial double-stranded RNAs. from PubMed. Read the original report for full context.
Health note: Findings in C. elegans and cultured human cells; human translation unproven.